- Report
- May 2025
- 50 Pages
Global
From €2427EUR$2,650USD£2,066GBP
- Report
- May 2025
- 50 Pages
Global
From €2427EUR$2,650USD£2,066GBP
Dimethoxanate is a type of respiratory drug used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It is a long-acting bronchodilator, meaning it helps to open up the airways and make breathing easier. Dimethoxanate is typically administered via inhalation, and is available in both metered-dose inhalers and dry powder inhalers. It is often used in combination with other medications, such as corticosteroids, to provide more effective relief.
Dimethoxanate is a widely used drug, and is available in many countries around the world. It is generally well-tolerated, with few side effects. Common side effects include throat irritation, dry mouth, and headache.
Some companies that produce dimethoxanate include GlaxoSmithKline, Boehringer Ingelheim, and Merck. Show Less Read more